Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir/Sofosbuvir in children with chronic HCV (14-35 kg)
NCT05854511Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Jun 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daclatasvir, sofosbuvir in hepatitis C virus infection, sponsored by Ain Shams University. Status: unknown.
02
Drugs
daclatasvirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT05854511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05854511.